The aim of this study was to investigate the association between the expression status of ZEB-1 and E-cadherin in HCC using immunohistochemistry, and to evaluate the clinical impact of the expression status of these proteins. This evidence concerns the gene ZEB1 and hepatocellular carcinoma.